<--- Back to Details
First PageDocument Content
Health / Pharmaceuticals policy / Clinical research / Federal Department of Home Affairs / Swissmedic / Pharmaceutical industry / Healthcare quality / Marketing authorization / Statistical process control / Pharmacovigilance / IB / Bioequivalence
Health
Pharmaceuticals policy
Clinical research
Federal Department of Home Affairs
Swissmedic
Pharmaceutical industry
Healthcare quality
Marketing authorization
Statistical process control
Pharmacovigilance
IB
Bioequivalence

ZL300_00_001e_WL Guidance document Variations and extensions HMV4

Add to Reading List

Source URL: www.swissmedic.ch

Download Document from Source Website

File Size: 434,97 KB

Share Document on Facebook

Similar Documents

PDF Document

DocID: 1xLRP - View Document

PDF Document

DocID: 1xJUP - View Document

DOC Document

DocID: 1xHuu - View Document

DOC Document

DocID: 1xAxm - View Document

PDF Document

DocID: 1xrVP - View Document